PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/19223544

Cancer Res. 2009 Mar 1 69 5 1851-7

Download in:

View as

General Info

PMID
19223544